Devi Thiagarajan, PhD, Postdoctoral Fellow

Devi Thiagarajan received her PhD from the Centre for DNA Fingerprinting and Diagnostics in India. Her thesis was titled “Epigenetic mechanisms underlying development: Role of Dnmt2 in RNA Processing”.

After specializing in epigenetic tools, she shifted her primary focus to cardiovascular complications. During her postdoctoral training at Wayne State University in Detroit, Michigan, she studied the implication of cytoskeleton organization in inducing inflammation using cell culture models.

Devi joined the Diabetes Research Program in December 2011. Working with Dr. Ravichandran Ramasamy, she studies the epigenetic modifications induced by aldose reductase and its toxic byproducts in ischemia-reperfusion as well as in hyperglycemic conditions.

1. Sowpati DT*, Thiagarajan D*, Sharma S, Sultana H, John R, Surani A, Mishra RK and Khosla S. An intronic DNA sequence within the mouse Neuronatin gene exhibits biochemical characteristics of an ICR and acts as a transcriptional activator in Drosophila. Mech. Dev. 2008, Nov-Dec; 125(11-12):963-73.

2. Thiagarajan D, Dev RR, Khosla S. The DNA methyltransferase Dnmt2 participates in RNA processing during cellular stress. Epigenetics. 2011. Jan; 103-13.

*- Joint first authors